In this #ASCO Educational Book📕 we summarize in EGFR mut🫁: ✏️New EGFR TKI options in early stage ✏️New options in metastatic setting ✏️Mechanisms of acquired resistance and new drugs 🧬 online at ascopubs.org/journal/edbk Thanks to Stephanie Saw Xiuning Le MD PhD Lizza Hendriks

Now that the educationals are all set, looking forward to next year’s scientific content! But first: #ESMO24! Filippo Pietrantonio Lizza Hendriks and many more!

Official pics of the All Ireland Lung Cancer Conference 2024 are out #AILCC24! Thanks to faculty, attendees & the organizing committee for an unforgettable event Till 2026 Beaumont RCSI Cancer Centre Trinity St James's Cancer Institute Cancer Research @UCC Ollscoil na Gaillimhe | University of Galway Cancer Trials Mater University Of Limerick St Vincent's University Hospital (SVUH) IASLC ESMO - Eur. Oncology

⏰NOW OUT‼️ #ASCO24🔥Educational Book #LCSM ✅New Tx Options for Oncogene-Addicted NSCLC Focusing on EGFR-Mutant Tumors 🎙️Stephanie Saw Xiuning Le MD PhD Lizza Hendriks Jordi Remon ✅NSCLC Metastatic Without Oncogenic Alterations 🎙️Dr. Nikolaj Frost Martin Reck OncoAlert ASCO

Important ⁦EORTC⁩ platform trial in patients with breast/ lung cancer with brain metastases presented by ⁦Lizza Hendriks⁩ ⁦Maastricht University⁩ Aim is to demonstrate role of SRS in the context of brain penetrant systemic trt Primary end point-time to CNS intervention

At ASCO24 multiple interesting and probably practice changing clinical trials will be presented, my stellar colleagues and I will discuss the highlights and practical take aways. Join us!

We have an exciting agenda for our roundtable on the latest progress in #LungCancer care following #ASCO24! Be sure to join Alfredo Addeo MD, Xiuning Le MD PhD and Lizza Hendriks to discuss #ADCs, targeted therapies, and much more. ⏰ 12th June at 5PM CEST Tune in for free ⬇️

Applications now open, very happy to be there! esmo.org/meeting-calend…

🌐 Enhance your #LungCancer knowledge with our #ASCO24 conference reports. Watch concise recaps and detailed discussions on #high5oncologyTV. high5oncology.tv/meeting-covera… Free for all HCPs! #Oncology #NSCLC #SCLC #Mesothelioma Noemi Reguart Dr Riyaz Shah Stephen V Liu, MD Alfredo Addeo MD

ASCO 2024 Highlight: Dr Lizza Hendriks , respiratory oncologist at Maastricht University Medical Center, highlights significant presentations on NSCLC. Key insights include: KRYSTAL-12 study on adagrasib for KRAS-G12C mutated NSCLC 👇

DOACs can have interactions with targeted therapy for NSCLC. However, alternatives such as LMWH are burdensome for patients. How to monitor and do this safely? Read our Parool of concept study just published in Br J Cancer OncoAlert #LCSM nature.com/articles/s4141…

Participate in the survey on targeted therapies in patients with oncogene-addicted #NSCLC in 2 cases: ✅ patients with brain metastases ✅ patients with progressive disease without alternative treatment options 👉Take the survey by 8 July: bit.ly/3XulMAs

Have you seen the faculty list for this meeting on Tolerance & Resistance to Targeted Therapy in #NSCLC?🔥🔥🔥#LCSM httr2024-iaslc.org/faculty Laura Attardi Alice Berger Lizza Hendriks Christine Lovly, MD, PhD Christian Rolfo Dr. Katerina Politi Montse Sanchez-Cespedes Lab Triparna Sen (Sen-Lab) Benjamin Neel IASLC

What evidences for the treatment of patients with stage III NSCLC excluded from trials?🤔 📌Auto-immune disorders 📌HIV 📌CV and lung comorbidities 🧐Do we need novel approaches? Check out our review! sciencedirect.com/science/articl… Lizza Hendriks Jarushka Naidoo Martina Bortolot

Do you need a deep dive in basic/TR aspects of resistance to targeted therapy? This conference is ideal! Dec13-15, Washington, &still time to submit abstract. Honored to be among faculty httr2024-iaslc.org. Hope to see you there #LCSM IASLC

New developments & approvals go fast in NSCLC! UPDATED & now living oncogene driven NSCLC CPG, with huge thanks to all collaborators ESMO - Eur. Oncology Francesco Cortiula Martin Reck Elene Mariamidze George Pentheroudakis & D Martins-Branco

1 augustus is longkankerdag, de dag om aandacht te vragen voor steun voor mensen met longkanker, betere longkankerzorg en nog veel meer. Wij vragen aandacht voor een bevolkingsonderzoek en het voorkomen van longkanker cutt.ly/tezdzel5 #wereldlongkankerdag

Comprehensive (and educational) review on the new challenges of early-stage #NSCLC, now that target therapies and ICIs are gaining more ground. Thanks Jordi Remon Jarushka Naidoo Lizza Hendriks #Lavaud & co-authors mdpi.com/2902160 #mdpicancers via Cancers MDPI

How do we treat in real-world practice patients with stIII #NSCLC who are under- or NOT represented in clinical trials? ☑️ PS>=2, unfit, frail ☑️ Elderly >75 yrs, older elderly (>80 yrs) ☑️ HIV, immunodeficient, autoimmune ☑️ Cardiovascular/respiratory morbidities A must-read

NSCLC brain mets tx is becoming increasingly complex with multiple new systemic treatments, as well as advances in local tx options. Very happy to have worked together with all co-authors on this comprehensive review. cancertreatmentreviews.com/action/showPdf… Jordi Remon and all others #LCSM